A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group

✍ Scribed by A. Wrzesień-Kuś; T. Robak; A. Wierzbowska; E. Lech-Marańda; A. Pluta; E. Wawrzyniak; A. Krawczyńska; K. Kuliczkowski; G. Mazur; M. Kiebiński; A. Dmoszyńska; M. Wach; A. Hellmann; W. Baran; J. Hołowiecki; S. Kyrcz-Krzemień; S. Grosicki

• Publisher: Springer
• Year: 2005
• Tongue: English
• Weight: 150 KB
• Volume: 84
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-005-1046-0